Microbiology diagnostic, preventive and therapeutic products are developed by INCELL scientists, quality managers and manufacturing staff alone or with collaborators. The work includes GMP components manufacturing; complex formulation and packaging; identification and testing of live organisms, active ingredients, adjuvants, and excipients; evaluating natural and recombinant biotechnology-derived products; and testing of vaccines.
	
	
		
 
	
	
		Graphics provide from National Institute of Allergy and Infectious Diseases.
	
	
		Vaccines and components in development include:
	
	
		- 
			Bacteria
		
- 
			Viruses
		
- 
			Cell Substrates
		
- 
			Adjuvants & Protectants
		
- 
			GMP Media & Solutions
		
- 
			Non-Needle Delivery Technologies
		
		Specific capabilities and activities include:
	
	
		- 
			Manufacturing of vaccines as whole live, killed, subunit, or particulate organisms
		
- 
			Manufacturing of small and pilot scale sterile liquid fill products
		
- 
			Formulation and delivery components
		
- 
			QA and QbD in product manufacturing
		
- 
			Bioassays, potency, purity and QC release testing for certificates of analysis
		
- 
			Defining product labeling and packaging
		
- 
			Cost of goods analysis and pricing
		
- 
			Reproducibility, stability, product analysis
		
- 
			Diagnostic products and devices
		
- 
			Follow-on laboratory studies support
		
- 
			Consulting: Process and product development
		
- 
			Biotechnology Applications
			
				- 
					Nucleic Acid Recombinant Technologies
				
- 
					Molecular Testing
				
- 
					Production Cells and Cell Lines
				
- 
					Monoclonal Antibodies
				
- 
					Diagnostics
				
- 
					Collaborative Planning for Clinical Study Design Testing